Stroke is a major burden worldwide due to unsatisfactory conventional treatments available today. Disability from a stroke ranks first among the causes of primary disability. [2.3] To date, the introduction of new methods of treatment contributes to the success of stroke treatment and greater patient survival. The use of urinary callidinogenase (Kalgen 0.15 PNA) as part of complex therapy for patients with cerebral infarction has an etiopathogenetically effective and rapid recovery of nervous function.
This work is licensed under a Creative Commons Attribution 4.0 International License.